Prevalence of Helicobacter Pylori on Patients With Chronic Inflammatory Bowel Disease (IBD) at the CHU of Guadeloupe

ConditionsHELICOBACTER PYLORI INFECTIONS Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorCentre Hospitalier Universitaire de la Guadeloupe

About this trial

Clinical and experimental data suggest that dysbiosis may play a pivotal role in the pathogenesis of intestinal bowel disease (IBD). However, to the best of our knowledge, the composition of gastric and of intestinal microbiome has never been investigated in a population with IBD according to the presence/absence of Helicobacter pylori (H. pylori) in the stomach.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

Biopsies

Treatment groups

100 Participants

are divided into 1 treatment group

Sponsors and collaborators

Centre Hospitalier Universitaire de la Guadeloupe

Lead sponsor

Source ClinicalTrials.gov